{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:58:36Z","timestamp":1791579516517,"version":"4.3.4"},"reference-count":131,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Neurodegenerative diseases, such as Alzheimer\u2019s, Parkinson\u2019s, and Huntington\u2019s disease,\nrepresent a significant global health challenge with limited therapeutic options. Protein\nmisfolding and aggregation, a common pathological hallmark in these disorders, have emerged\nas promising targets for therapeutic intervention. Molecular docking techniques have played a\npivotal role in the identification and design of small molecules that can modulate protein misfolding,\noffering new hope for effective treatments. This review provides an overview of recent\nadvancements in molecular docking techniques for targeting protein misfolding in neurodegenerative\ndiseases. We discuss the principles and methodologies behind molecular docking, including\nvarious scoring functions and algorithms employed for accurate ligand-protein interactions.\nAdditionally, we explore the use of molecular dynamics simulations and machine learning\napproaches to enhance the precision of docking studies. Furthermore, we highlight case studies\nand success stories where molecular docking has contributed to the discovery of potential drug\ncandidates for neurodegenerative diseases. These include compounds that inhibit amyloid-\u03b2 aggregation\nin Alzheimer\u2019s disease, \u03b1-synuclein oligomerisation in Parkinson\u2019s disease, and mutant\nhuntingtin aggregation in Huntington\u2019s disease. We also discuss the problems and restrictions\nof molecular docking related to neurodegenerative diseases, such as how to accurately\nshow the flexibility of proteins and why docking results need to be confirmed by experiments.\nWe also discuss the structural biology methods, such as cryo-electron microscopy and X-ray\ncrystallography, and how these techniques might help in improving molecular docking studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010298545241108062449","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:47:06Z","timestamp":1740030426000},"page":"1777-1795","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Advances in Molecular Docking Techniques for Targeting Protein Misfolding in Neurodegenerative Diseases"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-8157","authenticated-orcid":true,"given":"Kuldeep","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5819-371X","authenticated-orcid":true,"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Narayan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Goel Institute of Pharmacy and Sciences, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketki","family":"Rani","sequence":"additional","affiliation":[{"name":"Department of Chemistry,\nSGT College of Pharmacy, SGT University, Gurugram, 122505, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7220-5687","authenticated-orcid":true,"given":"Divya","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Porwal","sequence":"additional","affiliation":[{"name":"Department of Chemistry, FS College of Pharmacy and Research Center, FS College of Pharmacy and Research Centre, FS University, Shikohabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Chandra","family":"Sharma","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Devi Ahilya Vishwavidalaya, Indore, (M.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-6981","authenticated-orcid":true,"given":"Shivendra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.3390\/ijms241310809","volume":"24","author":"Ciurea A.V.","year":"2023","unstructured":"Ciurea A.V.; Mohan A.G.; Busuioc R.A.; Costin H.P.; Glavan L.A.; Corlatescu A.D.; Saceleanu V.M.; Unraveling molecular and genetic insights into neurodegenerative diseases: Advances in Understanding Alzheimer\u2019s, Parkinson\u2019s, and Huntington\u2019s Diseases and Amyotrophic Lateral Sclerosis. Int J Mol Sci  2023,24(13),10809","journal-title":"Int J Mol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","volume":"23","author":"Lamptey R.N.L.","year":"2022","unstructured":"Lamptey R.N.L.; Chaulagain B.; Trivedi R.; Gothwal A.; Layek B.; Singh J.; A review of the common neurodegenerative disorders: Current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci  2022,23(3),1851","journal-title":"Int J Mol Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"Guo T.","year":"2020","unstructured":"Guo T.; Zhang D.; Zeng Y.; Huang T.Y.; Xu H.; Zhao Y.; Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener  2020,15(1),40","journal-title":"Mol Neurodegener"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"a004507","DOI":"10.1101\/cshperspect.a004507","volume":"3","author":"Lindquist S.L.","year":"2011","unstructured":"Lindquist S.L.; Kelly J.W.; Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis. Cold Spring Harb Perspect Biol  2011,3(12),a004507","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"Meng X.Y.","year":"2011","unstructured":"Meng X.Y.; Zhang H.X.; Mezei M.; Cui M.; Molecular docking: a powerful approach for structure-based drug discovery. Curr Computeraided Drug Des  2011,7(2),146-157","journal-title":"Curr Computeraided Drug Des"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/nsr\/nww003","volume":"3","author":"Liu T.","year":"2016","unstructured":"Liu T.; Lu D.; Zhang H.; Zheng M.; Yang H.; Xu Y.; Luo C.; Zhu W.; Yu K.; Jiang H.; Applying high-performance computing in drug discovery and molecular simulation. Natl Sci Rev  2016,3(1),49-63","journal-title":"Natl Sci Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-017-0077-5","volume":"6","author":"Sweeney P.","year":"2017","unstructured":"Sweeney P.; Park H.; Baumann M.; Dunlop J.; Frydman J.; Kopito R.; McCampbell A.; Leblanc G.; Venkateswaran A.; Nurmi A.; Hodgson R.; Protein misfolding in neurodegenerative diseases: implications and strategies. Transl Neurodegener  2017,6(1),6","journal-title":"Transl Neurodegener"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.2174\/1570159X15666171016163510","volume":"16","author":"Baig M.H.","year":"2018","unstructured":"Baig M.H.; Ahmad K.; Rabbani G.; Danishuddin M.; Choi I.; Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders. Curr Neuropharmacol  2018,16(6),740-748","journal-title":"Curr Neuropharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3390\/molecules27092834","volume":"27","author":"Gnanaraj C.","year":"2022","unstructured":"Gnanaraj C.; Sekar M.; Fuloria S.; Swain S.S.; Gan S.H.; Chidambaram K.; Rani N.N.I.M.; Balan T.; Stephenie S.; Lum P.T.; Jeyabalan S.; Begum M.Y.; Chandramohan V.; Thangavelu L.; Subramaniyan V.; Fuloria N.K.; In Silico Molecular Docking Analysis of Karanjin against Alzheimer\u2019s and Parkinson\u2019s Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy. Molecules  2022,27(9),2834","journal-title":"Molecules"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.3390\/ijms231911085","volume":"23","author":"Pint&#xE9;r P.","year":"2022","unstructured":"Pint&#xE9;r P.; Alp&#xE1;r A.; The Role of Extracellular Matrix in Human Neurodegenerative Diseases. Int J Mol Sci  2022,23(19),11085","journal-title":"Int J Mol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"Lionta E.","year":"2014","unstructured":"Lionta E.; Spyrou G.; Vassilatis D.; Cournia Z.; Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem  2014,14(16),1923-1938","journal-title":"Curr Top Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1021\/acs.jafc.1c06110","volume":"70","author":"Vidal-Limon A.","year":"2022","unstructured":"Vidal-Limon A.; Aguilar-Toal&#xE1; J.E.; Liceaga A.M.; Integration of molecular docking analysis and molecular dynamics simulations for studying food proteins and bioactive peptides. J Agric Food Chem  2022,70(4),934-943","journal-title":"J Agric Food Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"311","author":"Kitchen D.B.","year":"2004","unstructured":"Kitchen D.B.; Decornez H.; Furr J.R.; Bajorath J.; Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov  2004,311(3),935-949","journal-title":"Nat Rev Drug Discov"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/ci800298z","volume":"49","author":"Korb O.","year":"2009","unstructured":"Korb O.; St&#xFC;tzle T.; Exner T.E.; Empirical scoring functions for advanced protein-ligand docking with PLANTS. J Chem Inf Model  2009,49(1),84-96","journal-title":"J Chem Inf Model"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"Ferreira L.","year":"2015","unstructured":"Ferreira L.; Dos Santos R.; Oliva G.; Andricopulo A.; Molecular docking and structure-based drug design strategies. Molecules  2015,20(7),13384-13421","journal-title":"Molecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"Agu P.C.","year":"2023","unstructured":"Agu P.C.; Afiukwa C.A.; Orji O.U.; Ezeh E.M.; Ofoke I.H.; Ogbu C.O.; Ugwuja E.I.; Aja P.M.; Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep  2023,13(1),13398","journal-title":"Sci Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e87133","DOI":"10.1371\/journal.pone.0087133","volume":"9","author":"T&#xF3;th G.","year":"2014","unstructured":"T&#xF3;th G.; Gardai S.J.; Zago W.; Bertoncini C.W.; Cremades N.; Roy S.L.; Tambe M.A.; Rochet J.C.; Galvagnion C.; Skibinski G.; Finkbeiner S.; Bova M.; Regnstrom K.; Chiou S.S.; Johnston J.; Callaway K.; Anderson J.P.; Jobling M.F.; Buell A.K.; Yednock T.A.; Knowles T.P.J.; Vendruscolo M.; Christodoulou J.; Dobson C.M.; Schenk D.; McConlogue L.; Targeting the intrinsically disordered structural ensemble of\u03b1-synuclein by small molecules as a potential therapeutic strategy for Parkinson\u2019s disease. PLoS One  2014,9(2),e87133","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ph17010022","volume":"17","author":"Niazi S.K.","year":"2023","unstructured":"Niazi S.K.; Mariam Z.; Computer-aided drug design and drug discovery: a prospective analysis. Pharmaceuticals (Basel)  2023,17(1),22","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3390\/biom13111613","volume":"13","author":"Iqbal D.","year":"2023","unstructured":"Iqbal D.; Alsaweed M.; Jamal Q.M.S.; Asad M.R.; Rizvi S.M.D.; Rizvi M.R.; Albadrani H.M.; Hamed M.; Jahan S.; Alyenbaawi H.; Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders. Biomolecules  2023,13(11),1613","journal-title":"Biomolecules"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/e24050593","volume":"24","author":"Iqbal D.","year":"2022","unstructured":"Iqbal D.; Rizvi S.M.D.; Rehman M.T.; Khan M.S.; Bin Dukhyil A.; AlAjmi M.F.; Alshehri B.M.; Banawas S.; Zia Q.; Alsaweed M.; Madkhali Y.; Alsagaby S.A.; Alturaiki W.; Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study. Entropy (Basel)  2022,24(5),593","journal-title":"Entropy (Basel)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"10532","DOI":"10.1021\/jm301508d","volume":"55","author":"Gitto R.","year":"2012","unstructured":"Gitto R.; De Luca L.; Ferro S.; Buemi M.R.; Russo E.; De Sarro G.; Chisari M.; Ciranna L.; Chimirri A.; Synthesis and biological characterization of 3-substituted 1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. Part 2. J Med Chem  2012,55(23),10532-10539","journal-title":"J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","volume":"24","author":"Parsons C.G.","year":"2013","unstructured":"Parsons C.G.; Danysz W.; Dekundy A.; Pulte I.; Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer\u2019s disease. Neurotox Res  2013,24(3),358-369","journal-title":"Neurotox Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2174\/1570159X16666180315142137","volume":"16","author":"Sehgal S.A.","year":"2018","unstructured":"Sehgal S.A.; Hammad M.A.; Tahir R.A.; Akram H.N.; Ahmad F.; Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design. Curr Neuropharmacol  2018,16(6),649-663","journal-title":"Curr Neuropharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.3390\/pharmaceutics14112425","volume":"14","author":"Siafaka P.I.","year":"2022","unstructured":"Siafaka P.I.; Okur M.E.; Erim P.D.;\u00c7a&#x11F;lar E.&#x15E;.;\u00d6zgen&#xE7; E.; G&#xFC;ndo&#x11F;du E.; K&#xF6;pr&#xFC;l&#xFC; R.E.P.; Karantas I.D.;\u00dcst&#xFC;nda&#x11F; Okur N.; Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today? Pharmaceutics  2022,14(11),2425","journal-title":"Pharmaceutics"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e17575","DOI":"10.1016\/j.heliyon.2023.e17575","volume":"9","author":"Qureshi R.","year":"2023","unstructured":"Qureshi R.; Irfan M.; Gondal T.M.; Khan S.; Wu J.; Hadi M.U.; Heymach J.; Le X.; Yan H.; Alam T.; AI in drug discovery and its clinical relevance. Heliyon  2023,9(7),e17575","journal-title":"Heliyon"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/molecules25061375","volume":"25","author":"Lin X.","year":"2020","unstructured":"Lin X.; Li X.; Lin X.; A Review on Applications of Computational Methods in Drug Screening and Design. Molecules  2020,25(6),1375","journal-title":"Molecules"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"Gao H.M.","year":"2008","unstructured":"Gao H.M.; Hong J.S.; Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol  2008,29(8),357-365","journal-title":"Trends Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"Peng C.","year":"2020","unstructured":"Peng C.; Trojanowski J.Q.; Lee V.M.Y.; Protein transmission in neurodegenerative disease. Nat Rev Neurol  2020,16(4),199-212","journal-title":"Nat Rev Neurol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"Murphy M.P.","year":"2010","unstructured":"Murphy M.P.; LeVine H.; Alzheimer\u2019s disease and the amyloid-&#x3B2; peptide. J Alzheimers Dis  2010,19(1),311-323","journal-title":"J Alzheimers Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.3233\/JAD-179935","volume":"64","author":"Gulisano W.","year":"2018","unstructured":"Gulisano W.; Maugeri D.; Baltrons M.A.; F&#xE0; M.; Amato A.; Palmeri A.; D\u2019Adamio L.; Grassi C.; Devanand D.P.; Honig L.S.; Puzzo D.; Arancio O.; Role of Amyloid-&#x3B2; and Tau Proteins in Alzheimer\u2019s Disease: Confuting the Amyloid Cascade. J Alzheimers Dis  2018,64(s1)(Suppl. S1),S611-S631","journal-title":"J Alzheimers Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"Rajmohan R.","year":"2017","unstructured":"Rajmohan R.; Reddy P.H.; Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer\u2019s disease Neurons. J Alzheimers Dis  2017,57(4),975-999","journal-title":"J Alzheimers Dis"},{"key":"ref=32","first-page":"1","author":"Bryan K.J.","year":"2009","unstructured":"Bryan K.J.; Lee H.G.; Perry G.; Smith M.A.; Casadesus G.; Transgenic mouse models of Alzheimer\u2019s Disease: Behavioral testing and considerations. Methods of Behavior Analysis in Neuroscience  2009,1","journal-title":"Methods of Behavior Analysis in Neuroscience"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","volume":"17","author":"Zhang H.","year":"2021","unstructured":"Zhang H.; Wei W.; Zhao M.; Ma L.; Jiang X.; Pei H.; Cao Y.; Li H.; Interaction between A&#x3B2; and tau in the pathogenesis of Alzheimer\u2019s disease. Int J Biol Sci  2021,17(9),2181-2192","journal-title":"Int J Biol Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fphar.2020.00356","volume":"11","author":"G&#xF3;mez-Benito M.","year":"2020","unstructured":"G&#xF3;mez-Benito M.; Granado N.; Garc&#xED;a-Sanz P.; Michel A.; Dumoulin M.; Moratalla R.; Modeling Parkinson\u2019s Disease With the Alpha-Synuclein Protein. Front Pharmacol  2020,11,356","journal-title":"Front Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"Stefanis L.","year":"2012","unstructured":"Stefanis L.;\u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med  2012,2(2),a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","volume":"33","author":"Venda L.L.","year":"2010","unstructured":"Venda L.L.; Cragg S.J.; Buchman V.L.; Wade-Martins R.;\u03b1-Synuclein and dopamine at the crossroads of Parkinson\u2019s disease. Trends Neurosci  2010,33(12),559-568","journal-title":"Trends Neurosci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","volume":"298","author":"Brundin P.","year":"2017","unstructured":"Brundin P.; Dave K.D.; Kordower J.H.; Therapeutic approaches to target alpha-synuclein pathology. Exp Neurol  2017,298(Pt B),225-235","journal-title":"Exp Neurol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/09727531221136349","volume":"30","author":"Kharel S.","year":"2023","unstructured":"Kharel S.; Ojha R.; Future of Monoclonal Antibody Therapy in Parkinson\u2019s Disease. Ann Neurosci  2023,30(1),8-10","journal-title":"Ann Neurosci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","volume":"14","author":"Dehay B.","year":"2015","unstructured":"Dehay B.; Bourdenx M.; Gorry P.; Przedborski S.; Vila M.; Hunot S.; Singleton A.; Olanow C.W.; Merchant K.M.; Bezard E.; Petsko G.A.; Meissner W.G.; Targeting\u03b1-synuclein for treatment of Parkinson\u2019s disease: mechanistic and therapeutic considerations. Lancet Neurol  2015,14(8),855-866","journal-title":"Lancet Neurol"},{"key":"ref=40","first-page":"65","volume":"5","author":"Schulte J.","year":"2011","unstructured":"Schulte J.; Littleton J.T.; The biological function of the Huntingtin protein and its relevance to Huntington\u2019s Disease pathology. Curr Trends Neurol  2011,5,65-78","journal-title":"Curr Trends Neurol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"176873","DOI":"10.1016\/j.ejphar.2024.176873","volume":"980","author":"Singh K.","year":"2024","unstructured":"Singh K.; Jain D.; Sethi P.; Gupta J.K.; Tripathi A.K.; Kumar S.; Sarker S.D.; Nahar L.; Guru A.; Emerging pharmacological approaches for Huntington\u2019s disease. Eur J Pharmacol  2024,980,176873","journal-title":"Eur J Pharmacol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-160205","volume":"5","author":"Kumar A.","year":"2016","unstructured":"Kumar A.; Ratan R.R.; Oxidative Stress and Huntington\u2019s Disease: The Good, The Bad, and The Ugly. J Huntingtons Dis  2016,5(3),217-237","journal-title":"J Huntingtons Dis"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"11795735221092517","DOI":"10.1177\/11795735221092517","volume":"14","author":"Ferguson M.W.","year":"2022","unstructured":"Ferguson M.W.; Kennedy C.J.; Palpagama T.H.; Waldvogel H.J.; Faull R.L.M.; Kwakowsky A.; Current and Possible Future Therapeutic Options for Huntington\u2019s Disease. J Cent Nerv Syst Dis  2022,14,11795735221092517","journal-title":"J Cent Nerv Syst Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pneurobio.2011.11.004","volume":"97","author":"Butler D.C.","year":"2012","unstructured":"Butler D.C.; McLear J.A.; Messer A.; Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins. Prog Neurobiol  2012,97(2),190-204","journal-title":"Prog Neurobiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"785703","DOI":"10.3389\/fncel.2021.785703","volume":"15","author":"Komatsu H.","year":"2021","unstructured":"Komatsu H.; Innovative Therapeutic Approaches for Huntington\u2019s Disease: From Nucleic Acids to GPCR-Targeting Small Molecules. Front Cell Neurosci  2021,15,785703","journal-title":"Front Cell Neurosci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","volume":"7","author":"Grad L.I.","year":"2017","unstructured":"Grad L.I.; Rouleau G.A.; Ravits J.; Cashman N.R.; Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring Harb Perspect Med  2017,7(8),a024117","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"Masrori P.","year":"2020","unstructured":"Masrori P.; Van Damme P.; Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol  2020,27(10),1918-1929","journal-title":"Eur J Neurol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","volume":"21","author":"Mackenzie I.R.A.","year":"2008","unstructured":"Mackenzie I.R.A.; Rademakers R.; The role of TDP-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol  2008,21,693","journal-title":"Curr Opin Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"Meneses A.","year":"2021","unstructured":"Meneses A.; Koga S.; O\u2019Leary J.; Dickson D.W.; Bu G.; Zhao N.; TDP-43 pathology in Alzheimer\u2019s disease. Mol Neurodegener  2021,16(1),84","journal-title":"Mol Neurodegener"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"Soto C.","year":"2018","unstructured":"Soto C.; Pritzkow S.; Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci  2018,21(10),1332-1340","journal-title":"Nat Neurosci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/prot.24285","volume":"81","author":"Mulligan V.K.","year":"2013","unstructured":"Mulligan V.K.; Chakrabartty A.; Protein misfolding in the late\u2010onset neurodegenerative diseases: Common themes and the unique case of amyotrophic lateral sclerosis. Proteins  2013,81(8),1285-1303","journal-title":"Proteins"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1124\/mol.115.097998","volume":"88","author":"Yuan H.","year":"2015","unstructured":"Yuan H.; Low C.M.; Moody O.A.; Jenkins A.; Traynelis S.F.; Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases. Mol Pharmacol  2015,88(1),203-217","journal-title":"Mol Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0306-4522(99)00392-9","volume":"94","author":"Zilles K.","year":"1999","unstructured":"Zilles K.; Q&#xFC; M.S.; K&#xF6;hling R.; Speckmann E.J.; Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: quantitative in vitro receptor autoradiography. Neuroscience  1999,94(4),1051-1061","journal-title":"Neuroscience"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"12467","DOI":"10.3390\/ijms222212467","volume":"22","author":"Padilla-God&#xED;nez F.J.","year":"2021","unstructured":"Padilla-God&#xED;nez F.J.; Ramos-Acevedo R.; Mart&#xED;nez-Becerril H.A.; Bernal-Conde L.D.; Garrido-Figueroa J.F.; Hiriart M.; Hern&#xE1;ndez-L&#xF3;pez A.; Arg&#xFC;ero-S&#xE1;nchez R.; Callea F.; Guerra-Crespo M.; Protein Misfolding and Aggregation: The Relatedness between Parkinson\u2019s Disease and Hepatic Endoplasmic Reticulum Storage Disorders. Int J Mol Sci  2021,22(22),12467","journal-title":"Int J Mol Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.2174\/1871527313666140917095514","volume":"13","author":"Ashraf G.","year":"2014","unstructured":"Ashraf G.; Greig N.; Khan T.; Hassan I.; Tabrez S.; Shakil S.; Sheikh I.; Zaidi S.; Akram M.; Jabir N.; Firoz C.; Naeem A.; Alhazza I.; Damanhouri G.; Kamal M.; Protein misfolding and aggregation in Alzheimer\u2019s disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets  2014,13(7),1280-1293","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Zhang Y.","year":"2023","unstructured":"Zhang Y.; Chen H.; Li R.; Sterling K.; Song W.; Amyloid\u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther  2023,8(1),248","journal-title":"Signal Transduct Target Ther"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrn2786","volume":"11","author":"Frost B.","year":"2010","unstructured":"Frost B.; Diamond M.I.; Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci  2010,11(3),155-159","journal-title":"Nat Rev Neurosci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"102062","DOI":"10.1016\/j.jbc.2022.102062","volume":"298","author":"Calabrese G.","year":"2022","unstructured":"Calabrese G.; Molzahn C.; Mayor T.; Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation. J Biol Chem  2022,298(7),102062","journal-title":"J Biol Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/life10070101","volume":"10","author":"Abramov A.Y.","year":"2020","unstructured":"Abramov A.Y.; Potapova E.V.; Dremin V.V.; Dunaev A.V.; Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration. Life (Basel)  2020,10(7),101","journal-title":"Life (Basel)"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.sbi.2008.12.007","volume":"19","author":"Moore R.A.","year":"2009","unstructured":"Moore R.A.; Taubner L.M.; Priola S.A.; Prion protein misfolding and disease. Curr Opin Struct Biol  2009,19(1),14-22","journal-title":"Curr Opin Struct Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1515\/revneuro-2016-0035","volume":"30","author":"Gandhi J.","year":"2019","unstructured":"Gandhi J.; Antonelli A.C.; Afridi A.; Vatsia S.; Joshi G.; Romanov V.; Murray I.V.J.; Khan S.A.; Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics. Rev Neurosci  2019,30(4),339-358","journal-title":"Rev Neurosci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/0963689717714102","volume":"26","author":"Galgano M.","year":"2017","unstructured":"Galgano M.; Toshkezi G.; Qiu X.; Russell T.; Chin L.; Zhao L.R.; Traumatic Brain Injury. Cell Transplant  2017,26(7),1118-1130","journal-title":"Cell Transplant"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"Ross C.A.","year":"2004","unstructured":"Ross C.A.; Poirier M.A.; Protein aggregation and neurodegenerative disease. Nat Med  2004,10(S7)(Suppl.),S10-S17","journal-title":"Nat Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrd3453","volume":"10","author":"Neef D.W.","year":"2011","unstructured":"Neef D.W.; Jaeger A.M.; Thiele D.J.; Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat Rev Drug Discov  2011,10(12),930-944","journal-title":"Nat Rev Drug Discov"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.apsb.2019.08.001","volume":"10","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Jiang X.; Feng F.; Liu W.; Sun H.; Degradation of proteins by PROTACs and other strategies. Acta Pharm Sin B  2020,10(2),207-238","journal-title":"Acta Pharm Sin B"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"Pinzi L.","year":"2019","unstructured":"Pinzi L.; Rastelli G.; Molecular Docking: Shifting Paradigms in Drug Discovery. Int J Mol Sci  2019,20(18),4331","journal-title":"Int J Mol Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/ddc2020017","volume":"2","author":"Oliveira T.","year":"2023","unstructured":"Oliveira T.; Silva M.; Maia E.; Silva A.; Taranto A.; Taranto A.G.; Virtual Screening Algorithms in Drug Discovery: A Review Focused on Machine and Deep Learning Methods. Drugs and Drug Candidates  2023,2(2),311-334","journal-title":"Drugs and Drug Candidates"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.drudis.2021.11.023","volume":"27","author":"Vijayan R.S.K.","year":"2022","unstructured":"Vijayan R.S.K.; Kihlberg J.; Cross J.B.; Poongavanam V.; Enhancing preclinical drug discovery with artificial intelligence. Drug Discov Today  2022,27(4),967-984","journal-title":"Drug Discov Today"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cbpa.2021.04.009","volume":"65","author":"Ghislat G.","year":"2021","unstructured":"Ghislat G.; Rahman T.; Ballester P.J.; Recent progress on the prospective application of machine learning to structure-based virtual screening. Curr Opin Chem Biol  2021,65,28-34","journal-title":"Curr Opin Chem Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1021\/ci100369f","volume":"51","author":"Kinnings S.L.","year":"2011","unstructured":"Kinnings S.L.; Liu N.; Tonge P.J.; Jackson R.M.; Xie L.; Bourne P.E.; A machine learning-based method to improve docking scoring functions and its application to drug repurposing. J Chem Inf Model  2011,51(2),408-419","journal-title":"J Chem Inf Model"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"8651","DOI":"10.3390\/ijms21228651","volume":"21","author":"Kreiser R.P.","year":"2020","unstructured":"Kreiser R.P.; Wright A.K.; Block N.R.; Hollows J.E.; Nguyen L.T.; LeForte K.; Mannini B.; Vendruscolo M.; Limbocker R.; Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers. Int J Mol Sci  2020,21(22),8651","journal-title":"Int J Mol Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1038\/emm.2014.117","volume":"47","author":"Ciechanover A.","year":"2015","unstructured":"Ciechanover A.; Kwon Y.T.; Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med  2015,47(3),e147","journal-title":"Exp Mol Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/cmdc.201900299","volume":"14","author":"Silva G.M.","year":"2019","unstructured":"Silva G.M.; Barcelos M.P.; Poiani J.G.C.; Hage-Melim L.I.S.; da Silva C.H.T.P.; Allosteric modulators of potential targets related to Alzheimer\u2019s Disease: A Review. ChemMedChem  2019,14(16),1467-1483","journal-title":"ChemMedChem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s42514-021-00086-5","volume":"4","author":"Zhang B.","year":"2022","unstructured":"Zhang B.; Li H.; Yu K.; Jin Z.; Molecular docking-based computational platform for high-throughput virtual screening. CCF Transactions on High Performance Computing  2022,4(1),63-74","journal-title":"CCF Transactions on High Performance Computing"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"114239","DOI":"10.1016\/j.ejmech.2022.114239","volume":"234","author":"Hua Y.","year":"2022","unstructured":"Hua Y.; Dai X.; Xu Y.; Xing G.; Liu H.; Lu T.; Chen Y.; Zhang Y.; Drug repositioning: Progress and challenges in drug discovery for various diseases. Eur J Med Chem  2022,234,114239","journal-title":"Eur J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1021\/acscombsci.5b00129","volume":"18","author":"Joshi P.","year":"2016","unstructured":"Joshi P.; Chia S.; Habchi J.; Knowles T.P.J.; Dobson C.M.; Vendruscolo M.; A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins. ACS Comb Sci  2016,18(3),144-153","journal-title":"ACS Comb Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40203-023-00173-1","volume":"11","author":"Vasanth Kanth T.L.B.","year":"2023","unstructured":"Vasanth Kanth T.L.B.; Raha A.; Vijay Murali R.M.; Yuvatha N.; Kumaran K.; Kirubakaran R.; ArulJothi, K.N. Repurposing of clinically proven bioactive compounds for targeted treatment of Alzheimer\u2019s disease using molecular docking approach. In Silico Pharmacol  2023,11(1),33","journal-title":"In Silico Pharmacol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fnmol.2017.00187","volume":"10","author":"Remondelli P.","year":"2017","unstructured":"Remondelli P.; Renna M.; The Endoplasmic Reticulum Unfolded Protein Response in Neurodegenerative Disorders and Its Potential Therapeutic Significance. Front Mol Neurosci  2017,10,187","journal-title":"Front Mol Neurosci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2174\/1570159X18666200128121920","volume":"18","author":"Singh R.K.","year":"2020","unstructured":"Singh R.K.; Recent Trends in the Management of Alzheimer\u2019s Disease: Current Therapeutic Options and Drug Repurposing Approaches. Curr Neuropharmacol  2020,18(9),868-882","journal-title":"Curr Neuropharmacol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.slasd.2023.02.006","volume":"28","author":"Kellogg G.E.","year":"2023","unstructured":"Kellogg G.E.; Cen Y.; Dukat M.; Ellis K.C.; Guo Y.; Li J.; May A.E.; Safo M.K.; Zhang S.; Zhang Y.; Desai U.R.; Merging cultures and disciplines to create a drug discovery ecosystem at Virginia commonwealth university: Medicinal chemistry, structural biology, molecular and behavioral pharmacology and computational chemistry. SLAS Discov  2023,28(6),255-269","journal-title":"SLAS Discov"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.addr.2006.08.002","volume":"58","author":"Mager D.E.","year":"2006","unstructured":"Mager D.E.; Quantitative structure\u2013pharmacokinetic\/pharmacodynamic relationships. Adv Drug Deliv Rev  2006,58(12-13),1326-1356","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2217\/nnm.09.37","volume":"4","author":"Nowacek A.","year":"2009","unstructured":"Nowacek A.; Kosloski L.M.; Gendelman H.E.; Neurodegenerative disorders and nanoformulated drug development. Nanomedicine (Lond)  2009,4(5),541-555","journal-title":"Nanomedicine (Lond)"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2174\/1568026623666221026091010","volume":"22","author":"Singh S.K.","year":"2022","unstructured":"Singh S.K.; Kumar A.; Singh R.B.; Ghosh P.; Bajad N.G.; Recent Applications of Bioinformatics in Target Identification and Drug Discovery for Alzheimer\u2019s Disease. Curr Top Med Chem  2022,22(26),2153-2175","journal-title":"Curr Top Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinbiochem.2018.06.011","volume":"59","author":"Sancesario G.M.","year":"2018","unstructured":"Sancesario G.M.; Bernardini S.; Alzheimer\u2019s disease in the omics era. Clin Biochem  2018,59,9-16","journal-title":"Clin Biochem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13321-023-00795-9","volume":"16","author":"Wang D.D.","year":"2024","unstructured":"Wang D.D.; Wu W.; Wang R.; Structure-based, deep-learning models for protein-ligand binding affinity prediction. J Cheminform  2024,16(1),2","journal-title":"J Cheminform"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.3390\/ijms21103517","volume":"21","author":"Bagyinszky E.","year":"2020","unstructured":"Bagyinszky E.; Giau V.V.; An S.A.; Transcriptomics in Alzheimer\u2019s Disease: Aspects and Challenges. Int J Mol Sci  2020,21(10),3517","journal-title":"Int J Mol Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"Johnson E.C.B.","year":"2020","unstructured":"Johnson E.C.B.; Dammer E.B.; Duong D.M.; Ping L.; Zhou M.; Yin L.; Higginbotham L.A.; Guajardo A.; White B.; Troncoso J.C.; Thambisetty M.; Montine T.J.; Lee E.B.; Trojanowski J.Q.; Beach T.G.; Reiman E.M.; Haroutunian V.; Wang M.; Schadt E.; Zhang B.; Dickson D.W.; Ertekin-Taner N.; Golde T.E.; Petyuk V.A.; De Jager P.L.; Bennett D.A.; Wingo T.S.; Rangaraju S.; Hajjar I.; Shulman J.M.; Lah J.J.; Levey A.I.; Seyfried N.T.; Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med  2020,26(5),769-780","journal-title":"Nat Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"679568","DOI":"10.3389\/fnins.2021.679568","volume":"15","author":"Li B.","year":"2021","unstructured":"Li B.; Zhao G.; Zhou Q.; Xie Y.; Wang Z.; Fang Z.; Lu B.; Qin L.; Zhao Y.; Zhang R.; Jiang L.; Pan H.; He Y.; Wang X.; Luo T.; Zhang Y.; Wang Y.; Chen Q.; Liu Z.; Guo J.; Tang B.; Li J.; Gene4PD: A Comprehensive Genetic Database of Parkinson\u2019s Disease. Front Neurosci  2021,15,679568","journal-title":"Front Neurosci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"Jankovic J.","year":"2008","unstructured":"Jankovic J.; Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry  2008,79(4),368-376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"18.6.1-18.6.33","DOI":"10.1002\/0471142905.hg1806s71","volume":"18","author":"Karolchik D.","year":"2011","unstructured":"Karolchik D.; Hinrichs A.S.; Kent W.J.; The UCSC Genome Browser. Curr Protoc Hum Genet  2011,18,18.6.1-18.6.33","journal-title":"Curr Protoc Hum Genet"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"D64","DOI":"10.1093\/nar\/gks1048","volume":"41","author":"Meyer L.R.","year":"2013","unstructured":"Meyer L.R.; Zweig A.S.; Hinrichs A.S.; Karolchik D.; Kuhn R.M.; Wong M.; Sloan C.A.; Rosenbloom K.R.; Roe G.; Rhead B.; Raney B.J.; Pohl A.; Malladi V.S.; Li C.H.; Lee B.T.; Learned K.; Kirkup V.; Hsu F.; Heitner S.; Harte R.A.; Haeussler M.; Guruvadoo L.; Goldman M.; Giardine B.M.; Fujita P.A.; Dreszer T.R.; Diekhans M.; Cline M.S.; Clawson H.; Barber G.P.; Haussler D.; Kent W.J.; The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res  2013,41(Database issue),D64-D69","journal-title":"Nucleic Acids Res"},{"key":"ref=92","first-page":"bav096","volume":"2016","author":"Herrero J.","year":"2016","unstructured":"Herrero J.; Muffato M.; Beal K.; Fitzgerald S.; Gordon L.; Pignatelli M.; Vilella A.J.; Searle S.M.; Amode R.; Brent S.; Ensembl comparative genomics resources. Database J Biol Databases Curation  2016,2016,bav096","journal-title":"Database J Biol Databases Curation"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bib\/bbw114","volume":"19","author":"Manzoni C.","year":"2018","unstructured":"Manzoni C.; Kia D.A.; Vandrovcova J.; Hardy J.; Wood N.W.; Lewis P.A.; Ferrari R.; Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform  2018,19(2),286-302","journal-title":"Brief Bioinform"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/pro.3987","volume":"30","author":"Digre A.","year":"2021","unstructured":"Digre A.; Lindskog C.; The Human Protein Atlas\u2014Spatial localization of the human proteome in health and disease. Protein Sci  2021,30(1),218-233","journal-title":"Protein Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"D781","DOI":"10.1093\/nar\/gks1004","volume":"41","author":"Haug K.","year":"2013","unstructured":"Haug K.; Salek R.M.; Conesa P.; Hastings J.; de Matos P.; Rijnbeek M.; Mahendraker T.; Williams M.; Neumann S.; Rocca-Serra P.; Maguire E.; Gonz&#xE1;lez-Beltr&#xE1;n A.; Sansone S.A.; Griffin J.L.; Steinbeck C.; MetaboLights\u2014an open-access general-purpose repository for metabolomics studies and associated meta-data. Nucleic Acids Res  2013,41(D1),D781-D786","journal-title":"Nucleic Acids Res"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"Kanehisa M.","year":"2000","unstructured":"Kanehisa M.; Goto S.; KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res  2000,28,27","journal-title":"Nucleic Acids Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"105395","DOI":"10.1016\/j.nbd.2021.105395","volume":"155","author":"Tomkins J.E.","year":"2021","unstructured":"Tomkins J.E.; Manzoni C.; Advances in protein-protein interaction network analysis for Parkinson\u2019s disease. Neurobiol Dis  2021,155,105395","journal-title":"Neurobiol Dis"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"Kanehisa M.","year":"2017","unstructured":"Kanehisa M.; Furumichi M.; Tanabe M.; Sato Y.; Morishima K.; KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res  2017,45(D1),D353-D361","journal-title":"Nucleic Acids Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/gb-2007-8-3-r39","volume":"8","author":"Vastrik I.","year":"2007","unstructured":"Vastrik I.; D\u2019Eustachio P.; Schmidt E.; Joshi-Tope G.; Gopinath G.; Croft D.; de Bono B.; Gillespie M.; Jassal B.; Lewis S.; Matthews L.; Wu G.; Birney E.; Stein L.; Reactome: a knowledge base of biologic pathways and processes. Genome Biol  2007,8(3),R39","journal-title":"Genome Biol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.3390\/ijms22094820","volume":"22","author":"La Cognata V.","year":"2021","unstructured":"La Cognata V.; Morello G.; Cavallaro S.; Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases. Int J Mol Sci  2021,22(9),4820","journal-title":"Int J Mol Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2021.07.01.450693","DOI":"10.1101\/2021.07.01.450693","author":"Quazi S.","year":"2021","unstructured":"Quazi S.; Gavas S.; Malik J.A.; Suman K.S.; Haider Z.; In-silico pharmacophore and Molecular Docking based drug discovery against Marburg Virus\u2019s Viral Protein 35; A potent of MAVD. bioRxiv  2021,2021.07.01.450693","journal-title":"bioRxiv"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/hmg\/ddz227","volume":"29","author":"Pradeepkiran J.A.","year":"2020","unstructured":"Pradeepkiran J.A.; Reddy A.P.; Yin X.; Manczak M.; Reddy P.H.; Protective effects of BACE1 inhibitory ligand molecules against amyloid beta-induced synaptic and mitochondrial toxicities in Alzheimer\u2019s disease. Hum Mol Genet  2020,29(1),49-69","journal-title":"Hum Mol Genet"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"105422","DOI":"10.1016\/j.compbiomed.2022.105422","volume":"145","author":"Nadh A.G.","year":"2022","unstructured":"Nadh A.G.; Revikumar A.; Sudhakaran P.R.; Nair A.S.; Identification of potential lead compounds against BACE1 through in-silico screening of phytochemicals of Medhya rasayana plants for Alzheimer\u2019s disease management. Comput Biol Med  2022,145,105422","journal-title":"Comput Biol Med"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.4155\/fmc.12.110","volume":"4","author":"Ray S.","year":"2012","unstructured":"Ray S.; Liu M.; Current understanding of LRRK2 in Parkinson\u2019s disease: biochemical and structural features and inhibitor design. Future Med Chem  2012,4(13),1701-1713","journal-title":"Future Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-0716-1209-5_4","volume":"2266","author":"Scarpino A.","year":"2021","unstructured":"Scarpino A.; Ferenczy G.G.; Keser\u0171 G.M.; Binding Mode Prediction and Virtual Screening Applications by Covalent Docking. Methods Mol Biol  2021,2266,73-88","journal-title":"Methods Mol Biol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/biomedicines10061432","volume":"10","author":"Jurcau A.","year":"2022","unstructured":"Jurcau A.; Molecular Pathophysiological Mechanisms in Huntington\u2019s Disease. Biomedicines  2022,10(6),1432","journal-title":"Biomedicines"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2021.02.09.430405","DOI":"10.1101\/2021.02.09.430405","author":"Quazi S.","year":"2021","unstructured":"Quazi S.; Malik J.; Capuzzo A.M.; Suman K.S.; Haider Z.; In-silico structural and molecular docking-based drug discovery against viral protein (VP35) of Marburg virus: A potent agent of MAVD. bioRxiv  2021,2021.02.09.430405","journal-title":"bioRxiv"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"566858","DOI":"10.3389\/fnins.2020.566858","volume":"14","author":"Rojas P.","year":"2020","unstructured":"Rojas P.; Ram&#xED;rez A.I.; Fern&#xE1;ndez-Albarral J.A.; L&#xF3;pez-Cuenca I.; Salobrar-Garc&#xED;a E.; Cadena M.; Elvira-Hurtado L.; Salazar J.J.; de Hoz R.; Ram&#xED;rez J.M.; Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement. Front Neurosci  2020,14,566858","journal-title":"Front Neurosci"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.3390\/molecules27144568","volume":"27","author":"Yang C.","year":"2022","unstructured":"Yang C.; Chen E.A.; Zhang Y.; Protein\u2013Ligand Docking in the Machine-Learning Era. Molecules  2022,27(14),4568","journal-title":"Molecules"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.3390\/ijms20225553","volume":"20","author":"Lakey-Beitia J.","year":"2019","unstructured":"Lakey-Beitia J.; Kumar D.J.; Hegde M.; Rao K.S.; Carotenoids as novel therapeutic molecules against neurodegenerative disorders: Chemistry and molecular docking analysis. Int J Mol Sci  2019,20(22),5553","journal-title":"Int J Mol Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"Kim S.","year":"2016","unstructured":"Kim S.; Thiessen P.A.; Bolton E.E.; Chen J.; Fu G.; Gindulyte A.; Han L.; He J.; He S.; Shoemaker B.A.; Wang J.; Yu B.; Zhang J.; Bryant S.H.; PubChem Substance and Compound databases. Nucleic Acids Res  2016,44(D1),D1202-D1213","journal-title":"Nucleic Acids Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"156276","DOI":"10.1155\/2014\/156276","volume":"2014","author":"Huang H.J.","year":"2014","unstructured":"Huang H.J.; Chang T.T.; Chen H.Y.; Chen C.Y.C.; Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine. Evid Based Complement Alternat Med  2014,2014(1),156276","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/379817","volume":"2015","author":"Khan S.","year":"2015","unstructured":"Khan S.; Ahmad K.; Alshammari E.M.A.; Adnan M.; Baig M.H.; Lohani M.; Somvanshi P.; Haque S.; Implication of caspase-3 as a common therapeutic target for multineurodegenerative disorders and its inhibition using nonpeptidyl natural compounds. BioMed Res Int  2015,2015,1-9","journal-title":"BioMed Res Int"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1016\/j.bmcl.2008.08.072","volume":"18","author":"Cozza G.","year":"2008","unstructured":"Cozza G.; Gianoncelli A.; Montopoli M.; Caparrotta L.; Venerando A.; Meggio F.; Pinna L.A.; Zagotto G.; Moro S.; Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening. Bioorg Med Chem Lett  2008,18,5672-5675","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=115","first-page":"539","volume":"2","author":"Pareek H.","year":"2011","unstructured":"Pareek H.; Thakur P.; Ray D.; Modeling and Docking Studies Of 4-Aminobutyrate Aminotransferase for Huntington\u2019s Disease. Int J Pharma Bio Sci  2011,2,539-549","journal-title":"Int J Pharma Bio Sci"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pbiomolbio.2022.08.007","volume":"175","author":"Rahman A.","year":"2022","unstructured":"Rahman A.; Saikia B.; Gogoi C.R.; Baruah A.; Advances in the understanding of protein misfolding and aggregation through molecular dynamics simulation. Prog Biophys Mol Biol  2022,175,31-48","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"Jumper J.","year":"2021","unstructured":"Jumper J.; Evans R.; Pritzel A.; Green T.; Figurnov M.; Ronneberger O.; Tunyasuvunakool K.; Bates R.;\u017d&#xED;dek A.; Potapenko A.; Highly accurate protein structure prediction with AlphaFold. Nature  2021,596,583-589","journal-title":"Nature"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H.; Shindyalov I.N.; Bourne P.E.; The Protein Data Bank. Nucleic Acids Res  2000,28(1),235-242","journal-title":"Nucleic Acids Res"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41592-021-01117-3","volume":"18","author":"Necci M.","year":"2021","unstructured":"Necci M.; Piovesan D.; Hoque M.T.; Walsh I.; Iqbal S.; Vendruscolo M.; Sormanni P.; Wang C.; Raimondi D.; Sharma R.; Zhou Y.; Litfin T.; Galzitskaya O.V.; Lobanov M.Y.; Vranken W.; Wallner B.; Mirabello C.; Malhis N.; Doszt&#xE1;nyi Z.; Erd\u0151s G.; M&#xE9;sz&#xE1;ros B.; Gao J.; Wang K.; Hu G.; Wu Z.; Sharma A.; Hanson J.; Paliwal K.; Callebaut I.; Bitard-Feildel T.; Orlando G.; Peng Z.; Xu J.; Wang S.; Jones D.T.; Cozzetto D.; Meng F.; Yan J.; Gsponer J.; Cheng J.; Wu T.; Kurgan L.; Promponas V.J.; Tamana S.; Marino-Buslje C.; Mart&#xED;nez-P&#xE9;rez E.; Chasapi A.; Ouzounis C.; Dunker A.K.; Kajava A.V.; Leclercq J.Y.; Aykac-Fas B.; Lambrughi M.; Maiani E.; Papaleo E.; Chemes L.B.;\u00c1lvarez L.; Gonz&#xE1;lez-Foutel N.S.; Iglesias V.; Pujols J.; Ventura S.; Palopoli N.; Ben&#xED;tez G.I.; Parisi G.; Bassot C.; Elofsson A.; Govindarajan S.; Lamb J.; Salvatore M.; Hatos A.; Monzon A.M.; Bevilacqua M.; Mi&#x10D;eti\u0107 I.; Minervini G.; Paladin L.; Quaglia F.; Leonardi E.; Davey N.; Horvath T.; Kovacs O.P.; Murvai N.; Pancsa R.; Schad E.; Szabo B.; Tantos A.; Macedo-Ribeiro S.; Manso J.A.; Pereira P.J.B.; Davidovi\u0107 R.; Veljkovic N.; Hajdu-Solt&#xE9;sz B.; Pajkos M.; Szaniszl&#xF3; T.; Guharoy M.; Lazar T.; Macossay-Castillo M.; Tompa P.; Tosatto S.C.E.; Critical assessment of protein intrinsic disorder prediction. Nat Methods  2021,18(5),472-481","journal-title":"Nat Methods"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1006\/jmbi.1999.2658","volume":"287","author":"Radhakrishnan I.","year":"1999","unstructured":"Radhakrishnan I.; P&#xE9;rez-Alvarado G.C.; Parker D.; Dyson H.J.; Montminy M.R.; Wright P.E.; Structural analyses of CREB-CBP transcriptional activator-coactivator complexes by NMR spectroscopy: implications for mapping the boundaries of structural domains. J Mol Biol  1999,287(5),859-865","journal-title":"J Mol Biol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/jmbi.1999.3110","volume":"293","author":"Wright P.E.","year":"1999","unstructured":"Wright P.E.; Dyson H.J.; Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol  1999,293(2),321-331","journal-title":"J Mol Biol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"eaat7778","DOI":"10.1126\/sciadv.aat7778","volume":"4","author":"Milles S.","year":"2018","unstructured":"Milles S.; Jensen M.R.; Lazert C.; Guseva S.; Ivashchenko S.; Communie G.; Maurin D.; Gerlier D.; Ruigrok R.W.H.; Blackledge M.; An ultraweak interaction in the intrinsically disordered replication machinery is essential for measles virus function. Sci Adv  2018,4(8),eaat7778","journal-title":"Sci Adv"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"9839","DOI":"10.1073\/pnas.1103270108","volume":"108","author":"Jensen M.R.","year":"2011","unstructured":"Jensen M.R.; Communie G.; Ribeiro E.A.; Martinez N.; Desfosses A.; Salmon L.; Mollica L.; Gabel F.; Jamin M.; Longhi S.; Ruigrok R.W.H.; Blackledge M.; Intrinsic disorder in measles virus nucleocapsids. Proc Natl Acad Sci USA  2011,108(24),9839-9844","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"167208","DOI":"10.1016\/j.jmb.2021.167208","volume":"433","author":"Ruff K.M.","year":"2021","unstructured":"Ruff K.M.; Pappu R.V.; AlphaFold and Implications for Intrinsically Disordered Proteins. J Mol Biol  2021,433(20),167208","journal-title":"J Mol Biol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/ph15010051","volume":"15","author":"Cruz-Vicente P.","year":"2021","unstructured":"Cruz-Vicente P.; Gon&#xE7;alves A.M.; Ferreira O.; Queiroz J.A.; Silvestre S.; Passarinha L.A.; Gallardo E.; Discovery of Small Molecules as Membrane-Bound Catechol-O-methyltransferase Inhibitors with Interest in Parkinson\u2019s Disease: Pharmacophore Modeling, Molecular Docking and In Vitro Experimental Validation Studies. Pharmaceuticals (Basel)  2021,15(1),51","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/07391102.2016.1166454","volume":"35","author":"Palakurti R.","year":"2017","unstructured":"Palakurti R.; Vadrevu R.; Identification of abelson tyrosine kinase inhibitors as potential therapeutics for Alzheimer\u2019s disease using multiple e-pharmacophore modeling and molecular dynamics. J Biomol Struct Dyn  2017,35(4),883-896","journal-title":"J Biomol Struct Dyn"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11030-021-10326-z","volume":"26","author":"Selvaraj C.","year":"2022","unstructured":"Selvaraj C.; Chandra I.; Singh S.K.; Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Mol Divers  2022,26(3),1893-1913","journal-title":"Mol Divers"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/geriatrics2010008","volume":"2","author":"Low J.","year":"2017","unstructured":"Low J.; Ho E.; Managing Ethical Dilemmas in End-Stage Neurodegenerative Diseases. Geriatrics (Basel)  2017,2(1),8","journal-title":"Geriatrics (Basel)"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2174\/1573409920666230914123005","volume":"20","author":"Singh K.","year":"2024","unstructured":"Singh K.; Bhushan B.; Singh B.; Advances in Drug Discovery and Design using Computer-aided Molecular Modeling. Curr Computeraided Drug Des  2024,20(5),697-710","journal-title":"Curr Computeraided Drug Des"},{"key":"ref=130","first-page":"37","volume":"8","author":"Hospital A.","year":"2015","unstructured":"Hospital A.; Go&#xF1;i J.R.; Orozco M.; Gelp&#xED; J.L.; Molecular dynamics simulations: advances and applications. Adv Appl Bioinform Chem  2015,8,37-47","journal-title":"Adv Appl Bioinform Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.3390\/ijms22094688","volume":"22","author":"Salman M.M.","year":"2021","unstructured":"Salman M.M.; Al-Obaidi Z.; Kitchen P.; Loreto A.; Bill R.M.; Wade-Martins R.; Advances in applying computer-aided drug design for neurodegenerative diseases. Int J Mol Sci  2021,22(9),4688","journal-title":"Int J Mol Sci"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010298545241108062449","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/239636\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010298545241108062449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:01:40Z","timestamp":1755000100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/239636\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":131,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010298545241108062449","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}